NSE: SPARC

SUN PHARMA ADV.RES.CO.LTD

Price history

-3.97% over 3M

2026-06-11Low 192.93 · High 277.572026-09-11

Performance

1W-1.73%
1M-4.05%
3M-14.42%
6M+57.60%
1Y+36.97%

52-week range

108289

Position in day range

Low 192.5669%High 197.55

SPARC stock DNA

Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.

Trend

Sideways

50-DMA ₹215.6

RSI (14)

51

Neutral momentum

Volatility (ATR)

4.05%

High

Close streak

4d down

Volume vs 20d avg

0.54x

From 52W high

-32.18%

Up from 52W low

+81.49%

Green days (20)

6/20

Monthly seasonality

Average monthly move for SPARC across the available price history.

-5.9
Jan
-0.7
Feb
-8.1
Mar
+19.2
Apr
+46.4
May
+10.1
Jun
-12.6
Jul
-3.9
Aug
-4.6
Sep
+4.0
Oct
-0.5
Nov
+0.3
Dec

Key statistics

Open

196.89

Day high

197.55

Day low

192.56

Prev close

196.01

Volume

4.76 L

Avg vol (20d)

8.82 L

52W high

289

52W low

108

SPARC quarterly results

All SPARC results →

Next results date

Awaiting intimation

Last results date

Reports published

Coverage coming soon

Revenue

₹39.92 cr

+314.1% YoY

Net profit

-₹20.78 cr

+59.9% YoY

Operating profit

-₹36.2 cr

+33.9% YoY

EPS

₹-0.64

+60.0% YoY

SUN PHARMA ADV.RES.CO.LTD (SPARC) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth
QuarterRevenueOperating profitNet profitOPMNet marginEPSProfit YoYProfit QoQ
Q1 FY272026-06-30₹39.92 cr-₹36.2 cr-₹20.78 cr-90.7%-52.1%₹-0.64+59.9%-101.2%
Q4 FY262026-03-31₹1,853 cr₹1,771 cr₹1,761 cr95.6%95.0%₹54.27+2290.2%
Q3 FY262025-12-31₹8.45 cr-₹59.21 cr-₹80.42 cr-700.7%-951.7%₹-2.48-6.0%
Q2 FY262025-09-30₹7.86 cr-₹68.28 cr-₹75.85 cr-868.7%-965.0%₹-2.34-46.2%
Q1 FY262025-06-30₹9.64 cr-₹54.76 cr-₹51.87 cr-568.0%-538.1%₹-1.60
TTM (last 4 quarters)₹1,909 cr₹1,607 cr₹1,584 cr84.2%83.0%₹48.81

Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.

Latest coverage

SPARC in Focus: Sun Pharma Adv.Res.Co.Ltd Share Price Opens Gap-Up at ₹204.00 on Rising Newsflow
Pharma & Healthcare

SPARC in Focus: Sun Pharma Adv.Res.Co.Ltd Share Price Opens Gap-Up at ₹204.00 on Rising Newsflow

Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹200.58, -2.69 (-1.34%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.

TrendRipperX Data Desk9 Sept 2026 7 min
Sun Pharma Adv.Res.Co.Ltd Share Price Opens Gap-Up at ₹205.87: What Is Driving SPARC Today, and the Levels That Matter
Pharma & Healthcare

Sun Pharma Adv.Res.Co.Ltd Share Price Opens Gap-Up at ₹205.87: What Is Driving SPARC Today, and the Levels That Matter

Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹203.27, -2.60 (-1.28%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.

TrendRipperX Data Desk9 Sept 2026 7 min
Sun Pharma Adv.Res.Co.Ltd Opens Gap-Up at ₹205.87 After M&A Update — Levels, Volumes and the Follow-Up to Track
Pharma & Healthcare

Sun Pharma Adv.Res.Co.Ltd Opens Gap-Up at ₹205.87 After M&A Update — Levels, Volumes and the Follow-Up to Track

Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹203.27, -2.60 (-1.28%) as the m&a story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.

TrendRipperX Data Desk8 Sept 2026 7 min
Sun Pharma Adv.Res.Co.Ltd Sees 2.6x Volume Spike — Should Investors Read This as a Trend or a One-Day Move?
Banking & Finance

Sun Pharma Adv.Res.Co.Ltd Sees 2.6x Volume Spike — Should Investors Read This as a Trend or a One-Day Move?

Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹199.58, +2.60 (+1.30%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.

TrendRipperX Data Desk3 Sept 2026 7 min
Sun Pharma Adv.Res.Co.Ltd Opens Gap-Up at ₹199.33 — Should Investors Read This as a Trend or a One-Day Move?
Pharma & Healthcare

Sun Pharma Adv.Res.Co.Ltd Opens Gap-Up at ₹199.33 — Should Investors Read This as a Trend or a One-Day Move?

Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹196.98, -2.35 (-1.19%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.

TrendRipperX Data Desk2 Sept 2026 7 min
Sun Pharma Adv.Res.Co.Ltd Share Price Drops 4.20% to ₹199.33: What Is Driving SPARC Today, and the Levels That Matter
Pharma & Healthcare

Sun Pharma Adv.Res.Co.Ltd Share Price Drops 4.20% to ₹199.33: What Is Driving SPARC Today, and the Levels That Matter

Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹199.33, -8.38 (-4.20%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.

TrendRipperX Data Desk31 Aug 2026 8 min
Sun Pharma Adv.Res.Co.Ltd Share Price Trades Flat at ₹195.66 — Here Is What Is Driving SPARC Today
Company Analysis

Sun Pharma Adv.Res.Co.Ltd Share Price Trades Flat at ₹195.66 — Here Is What Is Driving SPARC Today

Sun Pharma Adv.Res.Co.Ltd (SPARC) is at ₹195.66, +0.68 (+0.35%) — price is holding almost unchanged despite the coverage. Live board, the newsflow around it, and the levels that decide what happens next.

TrendRipperX Data Desk28 Aug 2026 5 min

Latest market news

Solar Industries (I) Share Price Trades Flat at ₹22,290.00: What Is Driving SOLARINDS Today, and the Levels That Matter
Energy

Solar Industries (I) Share Price Trades Flat at ₹22,290.00: What Is Driving SOLARINDS Today, and the Levels That Matter

Solar Industries (I) (SOLARINDS) trades at ₹22,290.00, -80.00 (-0.36%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.

TrendRipperX Data Desk12 Sept 2026 7 min
Jubilant Pharmova Share Price Trades Flat at ₹1,025.20 Today — Volumes, 52-Week Range and What to Watch Next
Companies

Jubilant Pharmova Share Price Trades Flat at ₹1,025.20 Today — Volumes, 52-Week Range and What to Watch Next

Jubilant Pharmova (JUBLPHARMA) trades at ₹1,025.20, -0.45 (-0.04%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.

TrendRipperX Data Desk12 Sept 2026 7 min
Coforge Share Price Opens Gap-Down at ₹1,807.30: What Is Driving COFORGE Today, and the Levels That Matter
Companies

Coforge Share Price Opens Gap-Down at ₹1,807.30: What Is Driving COFORGE Today, and the Levels That Matter

Coforge (COFORGE) trades at ₹1,846.50, +13.40 (+0.73%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.

TrendRipperX Data Desk11 Sept 2026 7 min
Aavas Financiers Share Price Edges Lower to ₹1,271.50 Today — Volumes, 52-Week Range and What to Watch Next
Companies

Aavas Financiers Share Price Edges Lower to ₹1,271.50 Today — Volumes, 52-Week Range and What to Watch Next

Aavas Financiers (AAVAS) trades at ₹1,271.50, -14.60 (-1.15%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.

TrendRipperX Data Desk11 Sept 2026 7 min
Morning Market Buzz, 12 September 2026: IPOs Tops the Coverage Ahead of Policy And Macro Data and Banks And NBFCs
Stock Market

Morning Market Buzz, 12 September 2026: IPOs Tops the Coverage Ahead of Policy And Macro Data and Banks And NBFCs

The most-covered market themes in the morning session on 12 September 2026 — IPOs, policy and macro data, banks and NBFCs — with our live numbers for each and links to the publishers running the story.

TrendRipperX Data Desk11 Sept 2026 5 min
Raymond Share Price Hits 52-Week High, Up 14.85%: What Is Driving RAYMOND Today, and the Levels That Matter
Industry

Raymond Share Price Hits 52-Week High, Up 14.85%: What Is Driving RAYMOND Today, and the Levels That Matter

Raymond (RAYMOND) trades at ₹1,002.80, +148.95 (+14.85%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.

TrendRipperX Data Desk11 Sept 2026 7 min

Price and history data from NSE via Upstox. For information only, not investment advice.